Lipid Nanoparticles

Ferulic acid (FA) is a ubiquitous natural plant bioactive with distinctive promise in neurodegenerative disorders. However, its therapeutic efficacy gets...

Various nano-sized protein and lipid complexes are being investigated as drug delivery systems. The encapsulation of more than one drug...

Solid lipid nanoparticles (SLNs) are being extensively exploited as topical ocular carrier systems to enhance the bioavailability of drugs. This...

A drawback of the current mRNA-lipid nanoparticle (LNP) COVID-19 vaccines is that they have to be stored at (ultra)low temperatures....

Lipid nanoparticles (LNPs) are the most clinically advanced delivery system for RNA-based drugs but have predominantly been investigated for intravenous...

The purpose of the study was to develop a novel, directly compressible, co-processed excipient capable of providing a controlled-release drug...

Introduction: Solid lipid nanoparticles (SLNs) are considered a promising system in enhancing the oral bioavailability of poorly water-soluble drugs; owing to...

21. August 2017 Solid lipid nanoparticles (SLN) containing rifabutin (RFB), with pulmonary administration purposes, were developed through a technique that...

Abstract Associating protein with nanoparticles is an interesting strategy to improve their bioavailability and biological activity. Solid lipid nanoparticles (SLN)...

  Abstract Solid lipid microparticles (SLM) were produced by produced by a two-step process that, firstly, involved the emulsification of...